Announced
Financials
Sources
Tags
Acquisition
Japan
measurement equipment
Domestic
Friendly
Pending
biomarkers
Medical Equipment
Single Bidder
Majority
Private
Synopsis
Otsuka Pharmaceutical, a firm that carries out R&D, produces products in its two core businesses which are pharmaceuticals for providing breakthrough treatments, agreed to acquire the measurement technology from Konica Minolta, a Japanese equipment and material manufacturer that operates globally. Financial terms were not disclosed. Through the acquisition of this SPFS technology higher diagnostic sensitivity is expected through Otsuka's development of unique biomarkers that have not been detectable by conventional testing methods. The technology is also expected to be used to support the research and development of innovative drugs within the Otsuka group of companies.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.